AI assistant
BIO-TECHNE Corp — Director's Dealing 2023
Aug 28, 2023
30718_dirs_2023-08-28_5cd05b07-cb36-44ee-aee6-8c1878d0b39f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2023-08-24
Reporting Person: Kelderman Kim (Pres. Diagnostics & Genom)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-24 | Common Stock | M | 2100 | $47.60 | Acquired | 21225 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-24 | Stock Option (Right to Buy) | $47.60 | M | 2100 | Disposed | 2026-08-07 | Common Stock (2100) | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $37.70 | 2025-05-01 | Common Stock (27392) | 27392 | Direct |
| Stock Option (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (84308) | 84308 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (69294) | 69294 | Direct |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (47952) | 47952 | Direct |
| Restricted Stock Units | $ | Common Stock (4980) | 4980 | Direct | |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (19456) | 19456 | Direct |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common stock (25944) | 25944 | Direct |
| Restricted Stock Units | $ | Common Stock (6984) | 6984 | Direct | |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (21704) | 21704 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (28940) | 28940 | Direct |
| Restricted Stock Units | $ | Common Stock (8191) | 8191 | Direct | |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (22043) | 22043 | Direct |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (29391) | 29391 | Direct |
Footnotes
F1: Fully exercisable.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F3: Options to purchase 11,988 shares vest on each of 8/5/2021, 8/5/2022, 8/5/2023 and 8/5/2024.
F4: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 12,972 shares are vested. Options to purchase 6,488 shares vest on 8/6/2024 and options to purchase 6,484 shares vest on 8/6/2025.
F6: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 7,236 shares vest on each of 8/15/2023, 8/15/2024 and 8/15/2026 and options to purchase 7,232 shares vest on 8/15/2025.
F8: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F9: Options to purchase 7,348 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027 and options to purchase 7,347 shares vest on 8/15/2026.